تقرير
Two cases of generalized eruptive lentiginosis in cutaneous T-cell lymphoma following mogamulizumab treatment.
| العنوان: | Two cases of generalized eruptive lentiginosis in cutaneous T-cell lymphoma following mogamulizumab treatment. |
|---|---|
| المؤلفون: | Vico-Alonso C; Dermatology and Venereology Department, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Madrid, Spain., Sánchez-Velázquez A; Dermatology and Venereology Department, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Madrid, Spain., Puerta-Peña M; Dermatology and Venereology Department, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Madrid, Spain., Garrido-Ruiz MC; Pathology Department, Dermatopathology Unit, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Madrid, Spain., Velasco-Tamariz V; Dermatology and Venereology Department, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Madrid, Spain., Ortiz-Romero PL; Dermatology and Venereology Department, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Madrid, Spain. |
| المصدر: | International journal of dermatology [Int J Dermatol] 2022 Dec; Vol. 61 (12), pp. e488-e489. Date of Electronic Publication: 2022 Jan 30. |
| نوع المنشور: | Case Reports; Letter |
| اللغة: | English |
| بيانات الدورية: | Publisher: Blackwell Science Country of Publication: England NLM ID: 0243704 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-4632 (Electronic) Linking ISSN: 00119059 NLM ISO Abbreviation: Int J Dermatol Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Oxford : Blackwell Science Original Publication: Philadelphia, Lippincott. |
| مواضيع طبية MeSH: | Lymphoma, T-Cell, Cutaneous*/chemically induced , Lymphoma, T-Cell, Cutaneous*/diagnosis , Lymphoma, T-Cell, Cutaneous*/drug therapy , Lentigo* , Skin Neoplasms*/chemically induced , Skin Neoplasms*/diagnosis , Skin Neoplasms*/drug therapy , Leukemia-Lymphoma, Adult T-Cell*/pathology, Humans ; Antibodies, Monoclonal, Humanized/adverse effects |
| References: | Hutchinson J. Outbreak of a larger crop of moles. Remarks as to possible connection with melanosis. J Cutan Med Dis Skin 1868; 1: 170-171. Woodhouse J, Maytin EV. Eruptive nevi of palms and soles. J Am Acad Dermatol 2005; 52: S96-S100. De S, Dogra S, Kanwar AJ, et al. Generalized eruptive lentiginosis induced by chemotherapy. Clin Exp Dermatol 2010; 35: e113-e115. Burian EA, Jemec GBE. Eruptive melanocytic nevi: a review. Am J Clin Dermatol 2019; 20: 669-682. Molloy K, Vico C, Ortiz-Romero PL, et al. Real-world experience of using mogamulizumab in relapsed/refractory mycosis fungoides/Sézary syndrome. Br J Dermatol 2021; 184: 978-981. Kim YH, Bagot M, Pinter-Brown L, et al. Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial. Lancet Oncol 2018; 19: 1192-1204. Friedland R, David M, Feinmesser M, et al. NB-UVB (311-312 nm)-induced lentigines in patients with mycosis fungoides: a new adverse effect of phototherapy. J Eur Acad Dermatol Venereol 2012; 26: 1158-1162. |
| المشرفين على المادة: | YI437801BE (mogamulizumab) 0 (Antibodies, Monoclonal, Humanized) |
| تواريخ الأحداث: | Date Created: 20220130 Date Completed: 20221115 Latest Revision: 20230222 |
| رمز التحديث: | 20230223 |
| DOI: | 10.1111/ijd.16102 |
| PMID: | 35094392 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1365-4632 |
|---|---|
| DOI: | 10.1111/ijd.16102 |